INmune Bio’s (INMB) treatment of epidermolysis bullosa received FDA orphan designation, according to a post on the agency’s site.Don't Miss Our ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

AGLE-102 is under clinical development by Aegle Therapeutics and currently in Phase II for Epidermolysis Bullosa.

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

The Penguin star joined 22,000 runners in the 26.2 mile race, where he raised money for his friend Emma Fogarty. She has a ...

Instead, Siddiqah was born missing skin on about 75 per cent of her body. The couple and their doctors were stunned. It turns out they were unknown carriers of a mutated gene that causes epidermolysis ...

StockNews.com lowered shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a hold rating to a sell rating in a research note published on Thursday morning. ABEO has been the subject of a ...

Go watch the Sisyphus video if you haven’t already. Goosebumps.

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that CEO ...

City Therapeutics appoints Andrew Orth as CEO, leveraging his expertise in RNA and gene therapies as the company advances its ...